Plasma P-Tau181 and Amyloid Markers in Alzheimer's Disease: A Method Comparison between Simoa and Lumipulse-Reference-Cited by-同舟云学术

Plasma P-Tau181 and Amyloid Markers in Alzheimer's Disease: A Method Comparison between Simoa and Lumipulse

Published:2024 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Quaresima Virginia,Pilotto Andrea,Trasciatti Chiara,Tolassi Chiara,Parigi Marta,Bertoli Diego,Mordenti Cristina,Galli Alice,Rizzardi Andrea,Caratozzolo Salvatore,Benussi Alberto,Ashton Nicholas J.,Blennow Kaj,Zetterberg Henrik,Giliani Silvia Clara,Brugnoni Duilio,Padovani Alessandro

Publisher

Elsevier BV

Reference52 articles.

1. Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease;D O T Alawode;J Intern Med,2021

2. A multicentre validation study of the diagnostic value of plasma neurofilament light;N J Ashton;Nat Commun

3. 2021b. Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology;N J Ashton;Acta Neuropathol

4. Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays;N J Ashton;Alzheimer's and Dementia,2023

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current perspectives on Alzheimer’s disease fluid biomarkers and future challenges: a narrative review;Journal of Laboratory and Precision Medicine;2024-07

2. Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer’s disease;2024-05-20

3. Plasma p-tau217 in Alzheimer’s disease: Lumipulse and ALZpath SIMOA head-to-head comparison;2024-05-03